As proposed in Fig. 6H, LMP2 and TAP2 may inhibit the oncogenesis and metastasis of cervical cancer cells by impairing the process of EMT and the Wnt/β-catenin signaling pathway, which will provide new targets and therapeutic strategies for the treatment of cervical cancer. Here, TAP2 is linked to cervical cancer.